LifeStance Health Group (NASDAQ:LFST) Stock Lifted to Strong-Buy by Wall Street Zen

Wall Street Zen upgraded shares of LifeStance Health Group (NASDAQ:LFST) from a buy rating to a strong-buy rating in a research note released on Saturday morning,Wall Street Zen reports.

LFST has been the subject of a number of other reports. KeyCorp increased their price objective on shares of LifeStance Health Group from $15.00 to $17.00 and gave the stock an “overweight” rating in a research note on Friday, November 6th. Barclays raised their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a report on Thursday, September 10th. JPMorgan Chase & Co. lifted their target price on LifeStance Health Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Thursday. Weiss Ratings reiterated a “hold (c)” rating on shares of LifeStance Health Group in a report on Wednesday, November 4th. Finally, Canaccord Genuity Group increased their price target on LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $14.86.

LifeStance Health Group Stock Down 0.5%

Shares of NASDAQ LFST traded down $0.07 during midday trading on Friday, reaching $14.08. The company’s stock had a trading volume of 3,728,905 shares, compared to its average volume of 6,598,220. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.17. LifeStance Health Group has a fifty-two week low of $6.01 and a fifty-two week high of $15.66. The stock has a market capitalization of $5.35 billion, a price-to-earnings ratio of 74.11 and a beta of 1.35. The stock has a 50 day simple moving average of $12.79 and a 200-day simple moving average of $9.67.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. LifeStance Health Group had a net margin of 4.29% and a return on equity of 4.82%. The business had revenue of $455.86 million for the quarter, compared to analyst estimates of $431.59 million. The business’s quarterly revenue was up 25.3% on a year-over-year basis. Equities research analysts predict that LifeStance Health Group will post 0.18 earnings per share for the current year.

Insider Buying and Selling

In other LifeStance Health Group news, COO Lisa K. Miller sold 14,663 shares of the stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $14.68, for a total value of $215,252.84. Following the completion of the sale, the chief operating officer owned 251,904 shares in the company, valued at $3,697,950.72. This trade represents a 5.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Ryan Pardo sold 2,216,585 shares of LifeStance Health Group stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $14.58, for a total transaction of $32,317,809.30. Following the completion of the transaction, the insider directly owned 334,935 shares of the company’s stock, valued at approximately $4,883,352.30. This trade represents a 86.87% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 2,861,235 shares of company stock worth $41,646,338. Insiders own 3.50% of the company’s stock.

Institutional Investors Weigh In On LifeStance Health Group

A number of institutional investors and hedge funds have recently modified their holdings of LFST. IFP Advisors Inc grew its holdings in LifeStance Health Group by 316.5% during the second quarter. IFP Advisors Inc now owns 3,694 shares of the company’s stock worth $40,000 after purchasing an additional 2,807 shares during the period. KBC Group NV acquired a new position in LifeStance Health Group during the first quarter worth approximately $29,000. Advisors Asset Management Inc. acquired a new position in LifeStance Health Group during the third quarter worth approximately $64,000. Signaturefd LLC raised its stake in LifeStance Health Group by 35.6% in the third quarter. Signaturefd LLC now owns 5,357 shares of the company’s stock valued at $64,000 after buying an additional 1,405 shares during the period. Finally, USA Financial Formulas bought a new stake in LifeStance Health Group in the third quarter valued at approximately $71,000. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.